Testosterone pellet therapy has gained further momentum and credibility over the last several months with a meta-analysis of data from 29 studies involving 120,000 men showing that this HRT procedure does not have negative cardiovascular risks.
Recent data emerging from the American College of Cardiology, show that testosterone therapy does not lead to adverse heart conditions and continues to have a positive impact on cognition, muscle mass, strength, bone density, metabolic function (and mood), as well as sexual performance.
As men age the amount of testosterone gradually declines and affects up to 13 million in the United States. While there has been some negative press regarding hormone replacement therapy (HRT) for both men and woman over the last several years, the majority of experts see its benefits when used inside a medically-guided program.
Today it is estimated that nearly one in 25 men over the age of 60 receive testosterone therapy, with this trend to expected to curve dramatically upward in the next few years, aided by the arrival of testosterone pellet therapy which is considered safer and more practical than cream or injection alternatives. While not normally covered by insurance, Medical Masters finds an overwhelmingly more popular response to pellet therapy than gels, patches and injections.
The reason for this is because the procedure is quick, painless and effective and does not require the drawing of blood. It can be done in one office visit requiring 1 cc lidocaine and a small incision in the hip area, where the pellets are deposited and closed up. Most patients cannot believe how effortless the process is and are out the door minutes later. It’s that quick.
It’s also drawing interest, since testosterone pellet therapy may have additional benefits related to aging, including preventing chronic diseases such as Alzheimer’s and Parkinson’s Disease. These tiny pellets are implanted under the skin and slowly release testosterone in steady, safe dosages while you work and sleep. They can last up to 4-6 months depending on the patient.
Despite what you may have read, testosterone pellet therapy carries few risks when done properly by an experienced medical practitioner. Less than 1% of cases experience any infection while less than 5% experience pellet ‘extrusion’.
There is also further good news reported by the Harvard Medical School: “In January 2004, a review article in the New England Journal of Medicine (NEJM) took a practical approach to what is perhaps the thorniest issue: whether testosterone treatments increase the risk for prostate cancer. The article says that testosterone doesn’t cause cancer, but that men taking it need to be monitored for prostate cancer “given the widespread, albeit poorly substantiated, concern” that the hormone may stimulate the growth of hidden cancer.”
Readers with a a further interest in HRT should read this recent testosterone pellet case study which centers on a 63-year old gentleman suffering from sleep deprivation, fatigue and depression.